Compagnie Lombard Odier SCmA - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 70 filers reported holding OCULAR THERAPEUTIX INC in Q4 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.

Quarter-by-quarter ownership
Compagnie Lombard Odier SCmA ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q2 2020$6,000
+100.0%
7000.0%0.00%
Q1 2020$3,0000.0%7000.0%0.00%
Q4 2019$3,000
+50.0%
7000.0%0.00%
Q3 2019$2,000
-33.3%
7000.0%0.00%
Q2 2019$3,0000.0%7000.0%0.00%
Q1 2019$3,0000.0%7000.0%0.00%
Q4 2018$3,000
-40.0%
7000.0%0.00%
Q3 2018$5,0000.0%7000.0%0.00%
Q2 2018$5,0000.0%7000.0%0.00%
Q1 2018$5,000
-16.7%
700
-50.0%
0.00%
Q4 2017$6,000
+50.0%
1,400
+100.0%
0.00%
Q3 2017$4,000
-33.3%
7000.0%0.00%
Q2 2017$6,0000.0%7000.0%0.00%
Q1 2017$6,000
-68.4%
700
-68.2%
0.00%
-100.0%
Q4 2016$19,0000.0%2,200
-18.5%
0.00%0.0%
Q3 2016$19,000
+533.3%
2,700
+285.7%
0.00%
Q2 2016$3,000
-57.1%
7000.0%0.00%
Q1 2016$7,0000.0%7000.0%0.00%
Q4 2015$7,0007000.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q4 2018
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,932,607$40,643,00015.56%
Lamond Capital Partners LLC 711,533$14,964,00015.19%
Polaris Venture Management Co. V, L.L.C. 1,230,009$25,867,00011.54%
NOTTINGHAM ADVISORS, INC. 171,985$3,617,0000.60%
Portolan Capital Management 122,518$2,577,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 160,000$3,365,0000.33%
Rotella Capital Management, Inc. 18,461$388,0000.32%
Monashee Investment Management LLC 28,834$606,0000.29%
DRIEHAUS CAPITAL MANAGEMENT LLC 335,498$7,056,0000.24%
BAILARD, INC. 55,000$1,157,0000.18%
View complete list of OCULAR THERAPEUTIX INC shareholders